Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18543281rdf:typepubmed:Citationlld:pubmed
pubmed-article:18543281lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:18543281lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18543281lifeskim:mentionsumls-concept:C0138741lld:lifeskim
pubmed-article:18543281lifeskim:mentionsumls-concept:C0475387lld:lifeskim
pubmed-article:18543281lifeskim:mentionsumls-concept:C0475388lld:lifeskim
pubmed-article:18543281lifeskim:mentionsumls-concept:C0681698lld:lifeskim
pubmed-article:18543281lifeskim:mentionsumls-concept:C1414461lld:lifeskim
pubmed-article:18543281lifeskim:mentionsumls-concept:C0205092lld:lifeskim
pubmed-article:18543281lifeskim:mentionsumls-concept:C1306673lld:lifeskim
pubmed-article:18543281lifeskim:mentionsumls-concept:C1521733lld:lifeskim
pubmed-article:18543281lifeskim:mentionsumls-concept:C0332185lld:lifeskim
pubmed-article:18543281pubmed:issue13lld:pubmed
pubmed-article:18543281pubmed:dateCreated2008-8-19lld:pubmed
pubmed-article:18543281pubmed:abstractTextEarly detection of small volume prostate cancer (PCa) has led to the concept of focal therapy to treat in an organ-sparing manner. We evaluated trends in pathologic staging among patients with localized PCa undergoing radical prostatectomy (RP), defining the frequency of unilateral cancers during 1988-1995, 1996-2000 and 2001-2006.lld:pubmed
pubmed-article:18543281pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18543281pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18543281pubmed:languageenglld:pubmed
pubmed-article:18543281pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18543281pubmed:citationSubsetIMlld:pubmed
pubmed-article:18543281pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18543281pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18543281pubmed:statusMEDLINElld:pubmed
pubmed-article:18543281pubmed:monthSeplld:pubmed
pubmed-article:18543281pubmed:issn1097-0045lld:pubmed
pubmed-article:18543281pubmed:authorpubmed-author:MoulJudd WJWlld:pubmed
pubmed-article:18543281pubmed:authorpubmed-author:PolascikThoma...lld:pubmed
pubmed-article:18543281pubmed:authorpubmed-author:MaddenJohn...lld:pubmed
pubmed-article:18543281pubmed:authorpubmed-author:SunLeonLlld:pubmed
pubmed-article:18543281pubmed:authorpubmed-author:MouravievVlad...lld:pubmed
pubmed-article:18543281pubmed:authorpubmed-author:MayesJanice...lld:pubmed
pubmed-article:18543281pubmed:copyrightInfo(c) 2008 Wiley-Liss, Inc.lld:pubmed
pubmed-article:18543281pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18543281pubmed:day15lld:pubmed
pubmed-article:18543281pubmed:volume68lld:pubmed
pubmed-article:18543281pubmed:ownerNLMlld:pubmed
pubmed-article:18543281pubmed:authorsCompleteYlld:pubmed
pubmed-article:18543281pubmed:pagination1380-6lld:pubmed
pubmed-article:18543281pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:meshHeadingpubmed-meshheading:18543281...lld:pubmed
pubmed-article:18543281pubmed:year2008lld:pubmed
pubmed-article:18543281pubmed:articleTitlePathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy.lld:pubmed
pubmed-article:18543281pubmed:affiliationDuke Prostate Center and Division of Urologic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA. polas001@mc.duke.edulld:pubmed
pubmed-article:18543281pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18543281pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18543281lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18543281lld:pubmed